Beyond Antibiotics: Emerging Strategies for Combating Bacterial Infection
May 04–07, 2026 | Village at Breckenridge, Breckenridge, CO, United States
Scientific Organizers:
Joseph P. Zackular, Kimberly Kline, Daria Van Tyne and Mariana X. Byndloss
In Person
On Demand
May 04–07, 2026 | Village at Breckenridge, Breckenridge, CO, United States
Scientific Organizers:
Joseph P. Zackular, Kimberly Kline, Daria Van Tyne and Mariana X. Byndloss
Available Formats:
In Person
On Demand
Supported by the Directors' Fund
Available Formats: = In Person = On Demand
Monday, May 4, 2026
Booking Function
Merchandise Options
Registration Options
Registration
4:00–8:00 PM
Welcome Mixer
6:00–8:00 PM
Tuesday, May 5, 2026
Breakfast
7:00–8:00 AM
Welcome and Keynote Address
8:00–9:00 AM
Speaker to be Announced
Phage Biology and Therapy: Basic
9:00–11:15 AM
Speaker to be Announced
Kimberley Seed †, University of California, Berkeley
Bacterial Immunity and Phage Immune Evasion Strategies in Vibrio Cholerae
Bacterial Immunity and Phage Immune Evasion Strategies in Vibrio Cholerae
Martha Clokie, University of Leicester
Getting Bacteriophages Closer to Clinical Development
Getting Bacteriophages Closer to Clinical Development
Short Talk(s) Chosen from Abstracts
Coffee Break
9:30–9:50 AM
Poster Setup
11:15–1:00 PM
On Own for Lunch
11:15–5:00 PM
Poster Viewing
1:00–10:00 PM
Symposia Spotlight 1: Late-breaking research presentations selected from abstract submissions
2:30–4:30 PM
Short Talks Chosen from Abstracts
Coffee Available
4:30–5:00 PM
Phage Biology and Therapy: Applied
5:00–7:00 PM
Daria Van Tyne, University of Pittsburgh
Functional Genomics and Phage Therapy for Antibiotic-Resistant Bacterial Infections
Functional Genomics and Phage Therapy for Antibiotic-Resistant Bacterial Infections
Paul E. Turner, Yale University
Leveraging Evolution to Fight Antibiotic Resistance with Phage Therapy
Leveraging Evolution to Fight Antibiotic Resistance with Phage Therapy
Susan M. Lehman, U.S. Food and Drug Administration
An in vitro Preclinical Model of Phage Dosing for Localized Infections
An in vitro Preclinical Model of Phage Dosing for Localized Infections
Short Talk(s) Chosen from Abstracts
Social Hour with Lite Bites
7:00–8:00 PM
Posters
7:30–10:00 PM
Wednesday, May 6, 2026
Breakfast
7:00–8:00 AM
Harnessing the Microbiome for Infection: Basic
8:00–11:00 AM
Mariana X. Byndloss, Vanderbilt University Medical Center
Host-Microbiota Metabolic Interactions during Infectious Gastroenteritis
Host-Microbiota Metabolic Interactions during Infectious Gastroenteritis
Joseph P. Zackular, University of Pennsylvania
Leveraging Ecology to Design New Therapeutic Strategies Against Clostridioides Difficile
Leveraging Ecology to Design New Therapeutic Strategies Against Clostridioides Difficile
Vanessa Sperandio, University of Wisconsin
Microbiota Control of EHEC Pathogenesis
Microbiota Control of EHEC Pathogenesis
Bärbel Stecher, Ludwig-Maximilians-Universität München
Using Defined Microbiota Communities to Reveal Novel Insights into Colonization Resistance Against Salmonella
Using Defined Microbiota Communities to Reveal Novel Insights into Colonization Resistance Against Salmonella
Short Talk(s) Chosen from Abstracts
Coffee Break
9:00–9:20 AM
Poster Setup
11:00–1:00 PM
On Own for Lunch
11:00–5:00 PM
Poster Viewing
1:00–10:00 PM
Career Roundtable
3:00–4:30 PM
Coffee Available
4:30–5:00 PM
Harnessing the Microbiome for Infection: Applied
5:00–7:00 PM
Speaker to be Announced
Julie A. Segre, National Institutes of Health
Human Skin Microbiome: From Friends to Foes
Human Skin Microbiome: From Friends to Foes
Silvia Caballero †, Bill & Melinda Gates Foundation
Microbiome Therapeutics in the Age of Multi-Drug Resistant Pathogens
Microbiome Therapeutics in the Age of Multi-Drug Resistant Pathogens
Short Talk(s) Chosen from Abstracts
Social Hour with Lite Bites
7:00–8:00 PM
Posters
7:30–10:00 PM
Thursday, May 7, 2026
Breakfast
7:00–8:00 AM
Leveraging Immunity to Combat Bacterial Infection: Basic
8:00–11:00 AM
Kimberly Kline, University of Geneva
Host-Pathogen Interactions in Mixed-Species Infections
Host-Pathogen Interactions in Mixed-Species Infections
Victor Torres, St. Jude Children's Research Hospital
Impact of Nutrition on Host-Pathogen Interactions during ESKAPE Pathogen Infection
Impact of Nutrition on Host-Pathogen Interactions during ESKAPE Pathogen Infection
Ann Marie Stanley, AstraZeneca
Monoclonal Antibodies to Prevent and Treat Bacterial Infections
Monoclonal Antibodies to Prevent and Treat Bacterial Infections
Short Talk(s) Chosen from Abstracts
Coffee Break
9:00–9:20 AM
On Own for Lunch
11:00–5:00 PM
Symposia Spotlight 2: Late-breaking research presentations selected from abstract submissions
2:30–4:30 PM
Short Talks Chosen from Abstracts
Coffee Available
4:30–5:00 PM
Leveraging Immunity to Combat Bacterial Infection: Applied
5:00–6:45 PM
Molly A Ingersoll, Institut Cochin & Institut Pasteur
Leveraging Mucosal Immunity in the Fight Against Recurrent Urinary Tract Infection
Leveraging Mucosal Immunity in the Fight Against Recurrent Urinary Tract Infection
Man-Wah Tan, Genentech, Inc.
Developing the Next-Generation of Therapeutics for Bacterial Infection
Developing the Next-Generation of Therapeutics for Bacterial Infection
Andreas Peschel †, Interfaculty Institute of Microbiology and Infection Medicine
Teichoic Acids at the Staphylococcus-Host Interface
Teichoic Acids at the Staphylococcus-Host Interface
Speaker to be Announced
Short Talk(s) Chosen from Abstracts
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
6:45–7:00 PM
Social Hour with Lite Bites
7:00–8:00 PM
Cash Bar
8:00–11:00 PM
Entertainment
8:00–11:00 PM
Friday, May 8, 2026
Departure
12:00–11:59 PM
Subscribe for Updates